Drug interaction between methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis. - Wikidata - awgldk - TriplyDB

Drug interaction between methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis.

Drug interaction between methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis.

http://www.wikidata.org/entity/Q37593506

about

Drug interaction between methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis.

http://www.wikidata.org/entity/Q37593506

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Drug interaction between metho ...... nts with rheumatoid arthritis.

@en

Drug interaction between metho ...... nts with rheumatoid arthritis.

@nl

type

label

Drug interaction between metho ...... nts with rheumatoid arthritis.

@en

Drug interaction between metho ...... nts with rheumatoid arthritis.

@nl

prefLabel

Drug interaction between metho ...... nts with rheumatoid arthritis.

@en

Drug interaction between metho ...... nts with rheumatoid arthritis.

@nl

P1433

Q37593506-8DDA79ED-2AE2-46B5-86E1-ABEBABBB10FD

P1476

Q37593506-22B5BC49-6540-41B6-88F3-D37DA01B3A74

P2093

Q37593506-09BDBB24-4F63-4A0F-AC08-5EDB57A0B991

Q37593506-189831F1-68AB-42EA-AF88-9D6B0F9F817C

Q37593506-1B7B2816-4275-4808-A5C8-453A207C0B16

Q37593506-2DD57428-52F2-4FFC-A853-49A97405583A

Q37593506-4B11DBA0-71CA-4EC0-8558-4E5FDF541365

Q37593506-866D743B-3C3D-43F9-A45E-34C829211F72

Q37593506-B9B9B9BB-9540-413B-8B1E-631B37BDF89C

Q37593506-CC5F35A0-0E48-4017-B0BF-2C8941325F9F

Q37593506-EFAB4436-601E-46D2-BB2B-AFC0E1089EA2

P2860

Q37593506-0C9A1360-166C-4DAC-9BE4-C46FE62E34E3

Q37593506-2A65A915-CC41-4FDA-AC7E-F26632DF0E2B

Q37593506-39591F98-AF2F-44D6-A88E-465CCA29CAAB

Q37593506-427994F3-3919-4102-850B-F55EE28492EE

Q37593506-46C65D72-1E6B-4E98-A065-298B175C33BE

Q37593506-4BDDA84C-6623-4E64-9D01-B38D5AAA4048

Q37593506-4EE16EB2-9BD8-409F-A960-9A02098EC36C

Q37593506-5E647CA5-F05A-45F2-AC89-BDE274E0E3AB

Q37593506-6A252792-12C0-4824-B585-7E1B93898296

Q37593506-6A5C8B9A-B9CE-491C-8A18-6BC1D2A2979C

P2888

Q37593506-BDEE5395-B013-40B1-A2A2-83F544782B89

P304

Q37593506-88918755-B687-448D-BBA9-DBE671803714

P31

Q37593506-6456195F-320B-4881-931C-E12A0D644F08

P356

Q37593506-4FCE7A3A-BA26-4821-BE02-F6BCE7FE61D5

P478

Q37593506-E605EE98-B058-412D-8DC0-1DA4D4964EB6

P577

Q37593506-279D0FA6-C80F-48C5-BC9D-E536930B6DF8

P6179

Q37593506-C8BE0A6A-7CF5-4F50-A3CB-58059CC5373E

P698

Q37593506-FC1C6250-4858-4265-B266-1F49DFB1C3D8

P932

Q37593506-D4647102-CE75-43F5-9634-B94C9C4B01AD

P356

S40780-017-0073-Z

P1433

Journal of pharmaceutical health care and sciences

P1476

Drug interaction between metho ...... nts with rheumatoid arthritis.

@en

P2093

Hiroshi Fujii

http://www.w3.org/2001/XMLSchema#string

Jun Nishigami

http://www.w3.org/2001/XMLSchema#string

Masae Okada

http://www.w3.org/2001/XMLSchema#string

Mitsuhiro Kawano

http://www.w3.org/2001/XMLSchema#string

Morihiro Okada

http://www.w3.org/2001/XMLSchema#string

Satoshi Morito

http://www.w3.org/2001/XMLSchema#string

Tsutomu Shimada

http://www.w3.org/2001/XMLSchema#string

Yoshimichi Sai

http://www.w3.org/2001/XMLSchema#string

Yukio Suga

http://www.w3.org/2001/XMLSchema#string

P2860

Functional characterization of human proton-coupled folate transporter/heme carrier protein 1 heterologously expressed in mammalian cells as a folate transporter

Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption

Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Targeting Low Disease Activity in Elderly-Onset Rheumatoid Arthritis: Current and Future Roles of Biological Disease-Modifying Antirheumatic Drugs

The pathogenesis of rheumatoid arthritis

Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states.

The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis.

Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis.

The epidemiology of rheumatoid arthritis.

P2888

s40780-017-0073-z

P304

7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40780-017-0073-Z

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1002393617

http://www.w3.org/2001/XMLSchema#string

P698

28116118

http://www.w3.org/2001/XMLSchema#string

P932

5244515

http://www.w3.org/2001/XMLSchema#string